Cognex Corporation $CGNX is Front Street Capital Management Inc.’s 2nd Largest Position

Front Street Capital Management Inc. raised its stake in shares of Cognex Corporation (NASDAQ:CGNX) by 1.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,322,588 shares of the scientific and technical instruments company’s stock after purchasing an additional 13,293 shares during the period. Cognex accounts for 8.4% of Front Street Capital Management Inc.’s portfolio, making the stock its 2nd largest position. Front Street Capital Management Inc. owned about 0.79% of Cognex worth $64,794,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of CGNX. Intech Investment Management LLC increased its position in Cognex by 124.5% during the fourth quarter. Intech Investment Management LLC now owns 98,451 shares of the scientific and technical instruments company’s stock worth $3,542,000 after purchasing an additional 54,600 shares during the last quarter. One Capital Management LLC acquired a new position in shares of Cognex in the 4th quarter valued at $1,945,000. Handelsbanken Fonder AB boosted its holdings in shares of Cognex by 76.3% in the 4th quarter. Handelsbanken Fonder AB now owns 758,831 shares of the scientific and technical instruments company’s stock valued at $27,303,000 after purchasing an additional 328,427 shares during the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in shares of Cognex during the 4th quarter valued at $753,000. Finally, Legal & General Group Plc increased its holdings in shares of Cognex by 11.1% during the 4th quarter. Legal & General Group Plc now owns 1,152,053 shares of the scientific and technical instruments company’s stock worth $41,451,000 after buying an additional 114,652 shares during the last quarter. Hedge funds and other institutional investors own 88.12% of the company’s stock.

Cognex Price Performance

Shares of CGNX opened at $62.62 on Friday. Cognex Corporation has a 12 month low of $34.60 and a 12 month high of $72.88. The stock’s 50-day moving average is $64.81 and its two-hundred day moving average is $56.09. The stock has a market cap of $10.42 billion, a PE ratio of 74.55 and a beta of 1.49.

Cognex (NASDAQ:CGNX) last posted its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.09. The business had revenue of $268.44 million during the quarter, compared to analyst estimates of $245.98 million. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The company’s revenue for the quarter was up 24.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.14 earnings per share. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, research analysts anticipate that Cognex Corporation will post 1.48 earnings per share for the current year.

Cognex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st were given a dividend of $0.085 per share. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 21st. Cognex’s payout ratio is presently 40.48%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Wall Street Zen upgraded Cognex from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. UBS Group set a $75.00 price target on Cognex in a research note on Tuesday, May 26th. Robert W. Baird set a $72.00 price objective on Cognex in a report on Friday, May 8th. Citigroup reiterated a “neutral” rating and set a $72.00 target price (up from $68.00) on shares of Cognex in a report on Monday, July 13th. Finally, Stephens increased their target price on shares of Cognex from $65.00 to $75.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $72.31.

Insider Activity

In related news, VP Darren Marc Long sold 20,252 shares of the firm’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the completion of the sale, the vice president directly owned 3,990 shares of the company’s stock, valued at approximately $264,696.60. This trade represents a 83.54% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mark Fennell sold 64,873 shares of the business’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the completion of the transaction, the insider owned 11,263 shares in the company, valued at $755,184.15. This represents a 85.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 224,847 shares of company stock worth $14,975,098. 1.70% of the stock is currently owned by company insiders.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.